Cancer diagnoses diminishes adherence to diabetes medications
the ONA take:
According to a new study published in the journal Diabetologia, patients with diabetes become less adherent to their antihyperglycemic medications after receiving a cancer diagnosis.
For the study, researchers sought to evaluate changes in adherence to antihyperglycemic medications used to treat diabetes after a diagnosis of cancer. Researchers identified 52,228 antihyperglycemic mediation users from the Eindhoven Cancer Registry-PHARMO Database Network in the Netherlands between 1998 and 2011. Of those, they identified 3,281 cases with cancer and 12,891 controls without cancer.
Results showed that before a cancer diagnosis, the medication possession ratio (MPR), an indicator for medication adherence, was increased by 0.10% per month. At the time of cancer diagnosis, researchers found that the MPR decreased by 6.3%, which continued to decline by 0.20% monthly thereafter.
Patients diagnosed with stage 4 cancer and those with gastroinestinal or pulmonary cancers had the largest declines in MPR. The initial 6% MPR decrease translates to a patient missing 2 days of their antihyperglycemic medications.
The findings suggest that a cancer diagnosis can diminish adherence to medications of patients' other chronic conditions.
Patients with diabetes become less adherent to their antihyperglycemic medications after receiving a cancer diagnosis.
Sign Up for Free e-newsletters
- Scalp Cooling With Dignicap May Reduce Alopecia During Chemotherapy for Breast Cancer
- Evolution of HER2-Positive Breast Cancer: Yesterday, Today, and Tomorrow
- Dedicated End-of-Life Education Program Improves Nurses' Care, Patient and Family Satisfaction
- Reflexology, Aromatherapy May Reduce Pain, Anxiety of Brachytherapy for Cervical Cancer
- Oncology Extended Care Clinic Reduced Urgent Cancer-Related ED Visits
- Hair Dyes and Cancer Risk (Fact Sheet)
- Taste Changes After Hematopoietic Stem Cell Transplant Affect QOL in Blood Cancers
- Hope, Optimism Reduce Psychological Distress in Advanced Cancer
- Mitomycin Extravasation Protocol
- Accurate Understanding of Capacity May Improve Workflow, Efficiency in Infusion Suite
- Nursing Practice Change Improved Chemo Administration, But Old Habits Die Hard
- Simple Adjustment Key to Paclitaxel Infusion Protocol That Reduced Hypersensitivity Reactions
- Online Program Aims to Assist With Clinical Trial Enrollment for Hematologic Cancers
- Education May Better Equip Nurses to Hold End-of-Life Conversations in Advanced Cancer
- Skipping the SICU Post Head and Neck Cancer Surgery May Improve Outcomes
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|